NO971991L - Heterosyklus-substituerte propensyrederivater som NMDA-antagonister - Google Patents

Heterosyklus-substituerte propensyrederivater som NMDA-antagonister

Info

Publication number
NO971991L
NO971991L NO971991A NO971991A NO971991L NO 971991 L NO971991 L NO 971991L NO 971991 A NO971991 A NO 971991A NO 971991 A NO971991 A NO 971991A NO 971991 L NO971991 L NO 971991L
Authority
NO
Norway
Prior art keywords
acid derivatives
propenoic acid
heterocycle
nmda antagonists
substituted propenoic
Prior art date
Application number
NO971991A
Other languages
English (en)
Other versions
NO971991D0 (no
NO313197B1 (no
Inventor
Boyd Lynn Harrison
Philip Lee Nyce
Robert Allan Farr
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO971991L publication Critical patent/NO971991L/no
Publication of NO971991D0 publication Critical patent/NO971991D0/no
Publication of NO313197B1 publication Critical patent/NO313197B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19971991A 1994-10-31 1997-04-29 Heterosyklus-substituerte propensyrederivater som NMDA- antagonister NO313197B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
PCT/US1995/012085 WO1996013501A1 (en) 1994-10-31 1995-09-21 Heterocycle substituted propenoic acid derivatives as nmda antagonists

Publications (3)

Publication Number Publication Date
NO971991L true NO971991L (no) 1997-04-29
NO971991D0 NO971991D0 (no) 1997-04-29
NO313197B1 NO313197B1 (no) 2002-08-26

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971991A NO313197B1 (no) 1994-10-31 1997-04-29 Heterosyklus-substituerte propensyrederivater som NMDA- antagonister

Country Status (21)

Country Link
US (3) US5563157B1 (no)
EP (1) EP0790994B1 (no)
JP (1) JP3934678B2 (no)
KR (1) KR100401138B1 (no)
CN (1) CN1068001C (no)
AT (1) ATE217307T1 (no)
AU (1) AU696423B2 (no)
CA (1) CA2202992C (no)
DE (1) DE69526668T2 (no)
DK (1) DK0790994T3 (no)
ES (1) ES2173198T3 (no)
FI (1) FI971831A (no)
HU (1) HU222372B1 (no)
IL (1) IL115791A (no)
MX (1) MX9703146A (no)
NO (1) NO313197B1 (no)
NZ (1) NZ293842A (no)
PT (1) PT790994E (no)
TW (1) TW336232B (no)
WO (1) WO1996013501A1 (no)
ZA (1) ZA959046B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
US6787651B2 (en) 2000-10-10 2004-09-07 Smithkline Beecham Corporation Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents
EP1436258A4 (en) * 2001-03-08 2005-03-23 Univ Emory ANTAGONISTS OF THE NMDA RECEPTOR DEPENDENT OF PH
EA201070077A1 (ru) * 2007-06-29 2010-08-30 Эмори Юниверсити Антагонисты nmda-рецепторов с нейропротективным действием

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69118539T2 (de) * 1990-07-16 1996-09-19 Merrell Dow Pharma Exzitatorische Aminosäureantagonisten
ATE154010T1 (de) * 1990-10-15 1997-06-15 Astra Ab 2-phenyl- und 2-thienyl-(2)-piperidinderivate mit neuroprotektiven eigenschaften
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
WO1994027964A1 (en) * 1993-05-27 1994-12-08 Merrell Dow Pharmaceuticals Inc. 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CA2202992A1 (en) 1996-05-09
ES2173198T3 (es) 2002-10-16
JP3934678B2 (ja) 2007-06-20
CN1068001C (zh) 2001-07-04
PT790994E (pt) 2002-08-30
EP0790994A1 (en) 1997-08-27
US5563157B1 (en) 1999-02-02
FI971831A0 (fi) 1997-04-29
ATE217307T1 (de) 2002-05-15
CA2202992C (en) 2003-05-13
DE69526668T2 (de) 2003-01-02
US6180786B1 (en) 2001-01-30
DE69526668D1 (de) 2002-06-13
NZ293842A (en) 1998-09-24
US5981553A (en) 1999-11-09
KR100401138B1 (ko) 2003-12-24
MX9703146A (es) 1997-06-28
EP0790994B1 (en) 2002-05-08
US5563157A (en) 1996-10-08
IL115791A0 (en) 1996-01-19
IL115791A (en) 2000-09-28
HUT77174A (hu) 1998-03-02
CN1161696A (zh) 1997-10-08
AU3638795A (en) 1996-05-23
JPH10508019A (ja) 1998-08-04
WO1996013501A1 (en) 1996-05-09
ZA959046B (en) 1996-05-17
NO971991D0 (no) 1997-04-29
DK0790994T3 (da) 2002-08-26
HU222372B1 (hu) 2003-06-28
AU696423B2 (en) 1998-09-10
FI971831A (fi) 1997-04-29
NO313197B1 (no) 2002-08-26
TW336232B (en) 1998-07-11

Similar Documents

Publication Publication Date Title
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
SE9504661D0 (sv) New compounds
EE03869B1 (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DK0891325T3 (da) Para-substituerede phenylpropansyrederivater som integrinantagonister
NO20033732L (no) N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser.
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
DE69830504D1 (de) Antithrombotische mitteln
PT977741E (pt) Derivados de fenilo substituido, sua preparacao e utilizacao
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
ATE375985T1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
ATE259813T1 (de) Triazolopyrimidinderivate
NO971991D0 (no) Heterosyklus-substituerte propensyrederivater som NMDA-antagonister
SE9902387D0 (sv) New pharmaceutically active compounds
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
DK0888340T3 (da) 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
TR199903001T2 (xx) 2-{4-$4-(4,5-Dikloro-2-metilimidazol-1-YL) Butil]-1-piperazinil}-5-floropirimidin, haz�rlan��� ve tedavi edici olarak kullan�m�.
YU38498A (sh) Derivati 2-(arilfenil)amino-imidazolina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees